Table 2. Demographic and clinical variables between male and female groups.
Variables | Male (n=13) | Female (n=42) | p-value |
---|---|---|---|
Age (years) | 41.38±18.21 | 50.12±17.26 | 0.12 |
Treatment duration (months) | 8.31±8.98 | 16.79±19.80 | 0.14 |
PRL level before PEG (ng/ml) | 14.41±8.73 | 15.52±24.23 | 0.87 |
PRL level after PEG (ng/ml) | 10.87±7.12 | 11.42±13.61 | 0.89 |
PEG-precipitated PRL (%) | 25.33±11.26 | 23.64±11.86 | 0.65 |
Macroprolactinemia (yes/no)* | 1/13 | 1/42 | 0.42 |
* Fisher's Exact Test, PRL; prolactin